Following proteolytic conversion of fibrinogen to fibrin, clot assembly commences with formation of double-stranded fibrils that subsequently branch extensively in forming a three-dimensional network. Plasmin digests of fibrin clots that had first been covalently crosslinked by plasma transglutaminase (factor XIIIa) contained multimeric proteolytic fragments composed of crosslinked outer (D) domains of neighboring fibrin molecules. Two of these were larger than the well-known "D dimer" fragment and corresponded to D trimers and D tetramers, respectively. Whereas D dimers originate from crosslinked D domains at bimolecular junctions within two-stranded fibrils, D trimers and D tetramers evidently arise through crosslinking of contiguous D domains at trimolecular and tetramolecular junctions or at fibril branch points, respectively. Measurement of the widths of fibrils comprising trifunctional branches in thin fiber networks revealed tetramolecular branch points, which are formed by bifurcation of two double-stranded fibrils. In addition, another type of trifunctional structure, which we term the trimolecular branch point, was composed of three double-stranded fibrils. Crosslinking of D domains to form trimers may occur at this type ofjunction. These findings add to our understanding of the crosslinking arrangements that stabilize fibrin clot structure and the ways that fibrin molecules polymerize to form branches in the clot matrix.
Following proteolytic conversion of fibrinogen to fibrin, polymer assembly commences with formation of doublestranded fibrils in which fibrin molecules, by virtue of noncovalent intermolecular interactions between outer (D) and central (E) domains (1) (2) (3) (4) (5) (6) , are arranged in a staggered overlapping manner (7) (8) (9) (10) (11) (12) (13) (Fig. 1) . Subsequently, lateral fibril associations result in increased fiber thickness (11, (16) (17) (18) , which is believed to account for interfibril connections and the trifunctional branching structures that comprise the three-dimensional matrix (11, (18) (19) (20) (21) . In the presence of plasma transglutaminase (factor XIIIa) and Ca2', fibrin molecules undergo covalent crosslinking by formation of E-(y-glutamyl)lysine [E-('y-Glu)Lys] isopeptide bonds (22, 23) . Intermolecular crosslinking between D domains forms dimers (24) , which occur as reciprocal bridges between a lysine at position 406 of one 'y chain and a glutamine at position 398 or 399 of another (25) (26) (27) (28) . In addition, slower intermolecular crosslinking among a chains creates oligomers and larger a-chain polymers (29) (30) (31) .
Plasmin digestion of crosslinked fibrin results in early release of crosslink-containing a-chain segments from core structures (32) (33) (34) (35) (36) . Thus, their existence in fibrin does not contribute significantly to the structure of major intermediate or terminal plasmin core fragments. In contrast, the intermolecular e-(y-Glu)Lys y-chain bonds result in degradation products unique to crosslinked fibrin, of which the bimolecular fragment, "D dimer," is the most abundant and best characterized (32, (37) (38) (39) . Crosslinked core derivatives larger than D dimer are known to exist (36, (40) (41) (42) (43) (44) (45) , each of which is postulated (36, (43) (44) (45) to contain one or more E domains (e.g., DY, YY, DXD).
The presence of Ca2+ confers resistance against plasmin cleavage in the COOH-terminal region of the fibrin(ogen) 'y chain (46) . This results in retention of the COOH-terminal segment containing the crosslinking site and consequent preservation of D dimer fragments in advanced digests of crosslinked fibrin (47) (48) (49) , whereas intermediate derivatives containing E domains are eventually all consumed.
In this study, we analyzed the components in plasmin digests of crosslinked fibrin and identified two previously unrecognized crosslinked fragments larger than D dimer, corresponding to D trimers and D tetramers. These crosslinked fragments evidently originate from trimolecular or tetramolecular junctions or fibril branch points within the fibrin network.
MATERIALS AND METHODS
Crosslinking and Plasmin Digestion of Fibrin. To purified human fibrinogen (2.5-3 mg/ml) in 0.15 M NaCl/10 mM Tris HCl, pH 7.4, buffer was added plasma factor XIII (50) (2-5 Loewy units/ml), CaCl2 (2-10 mM), and a-thrombin (1-2 units/ml), and the mixture was incubated at room temperature for 2-5 hr. The crosslinked clots were then subjected to syneresis, washed, suspended at 370C in a0.1 M Tris-HCl (pH 8.6) buffer containing EDTA (10 mM) or CaCl2 (10 mM) , and plasmin (51) (0.9-1.0 unit/ml). Aliquots of digest samples were added to an equal volume of an aprotinin solution (500 kallikrein inhibitor units/ml) for subsequent analysis.
Electrophoretic/Immunologic Procedures. Anti-D, anti-E, and anti-S carboxymethylated (S-CM) y and /at chains were prepared in rabbits. NaDodSO4/PAGE was carried out on cylindrical gels (56) ; crossed immunoelectrophoresis of such gels was conducted as described (57) . Two-dimensional NaDodSO4/PAGE was carried out on unreduced specimens in the first dimension (3 mm; 4.5% gels), and in the second dimension after reduction with 10% 2-mercaptoethanol into a 1.5-mm-thick gradient slab gel (5-23% polyacrylamide) containing Laemmli resolving buffer (58) . Immunoblotting was carried out on samples that had been separated by NaDod-S04/PAGE on a 3% stacker/7% resolving slab gel (58), electroblotted to nitrocellulose paper, and probed with either 1251-labeled rabbit anti-y-or anti-a-chain IgG.
Amino Acid Sequence Analyses. A reduced (5% 2-mercaptoethanol) crosslinked fibrin digest was separated on 7.5% polyacrylamide gels (58) and electroblotted to a polyvinylidene difluoride membrane (59) . Peptide-containing bands were excised and subjected directly to automated sequencing on a model 477A Applied Biosystems pulsed liquid-phase sequencer with a model 120A on-line phenylthiohydantoin amino acid analyzer.
Fragment Preparation and Electron Microscopy. An early monomeric D fragment (D1) was isolated from an intermediate plasmin digest of fibrinogen (60) . A D trimer/D tetramerenriched fraction was prepared from a digest of a crosslinked clot by selective pooling of fractions that had been rechromatographed on Sepharose 4B-CL in 50 mM Tris.HCI/1.0 M NaCI, pH 7.5, buffer. D dimer-containing fractions were pooled and rechromatographed to homogeneity.
For transmission electron microscopy (TEM), samples were dialyzed against 0.15 M ammonium acetate/30% (vol/vol) glycerol solution, pH 7, diluted to =30 ,ug/ml, sprayed onto mica discs, and rotary shadowed with platinumcarbon. For scanning TEM (STEM), samples were diluted to 5-10 ,ug/ml in 0.15 M NaCI/10 mM Hepes, pH 7, buffer, applied to a thin carbon film, and freeze-dried (60) .
Samples of a,3-fibrin for critical point drying were prepared from fibrinogen (50 pg/ml in 10 mM Tris HCI/0.15 M NaCI/5 mM EDTA, pH 7.4, buffer) after thrombin addition (2 units/ml) and overnight incubation at room temperature. P-Fibrin was processed after overnight incubation at 14 10C in a 10 mM Tris HCI/0.15 M NaCi, pH 7.4, buffer, to which copperhead venom procoagulant enzyme (61), 0.13 unit/ml, had been added.
TEM was carried out in a Philips 400 electron microscope at 60-80 kV. High-resolution STEM (62) Fig. 2A) revealed a precipitin arc extending from the gel origin to the region of the E band. Distinct precipitin arcs against anti-E were observed only in the region corresponding to the DY band (arrow) and fragment E. Similarly, a precipitin arc against each of the D-containing fragments was clearly revealed in the advanced digest sample (Fig. 2B) , whereas only the E fragment formed a precipitin arc against anti-E.
The peptides comprising these digest components were investigated by two-dimensional electrophoretic analysis of an advanced digest ( 3 and 4) . In addition, three weak reactions were observed in the plasmin digest sample (lane 4) in a band that was cathodal to the (/Y)2 position (-95 kDa), in a band migrating near the position of the intact y chain (-55 kDa), and in a band migrating near the tracking dye front. This finding, plus related studies (data not shown) in which we have identified bands larger than y dimer reacting with both anti-a-and anti-y-chain antibodies, suggests that small pop (Fig. 3A) from which they arise. D dimers (Fig. 3C) Fig. 3D; Fig. 3 E-G Fig. 3D Fig. 3D ; Fig. 31 ). Aggregates larger than trimeric and tetrameric structures were commonly seen ( Fig. 3 H and L (Fig. 3) ; the remainder had masses <150 kDa. Mass analysis of D1 and D dimer preparations showed a monotonic particle distribution clustering around 100 and 200 kDa, respectively. Only rarely (<5%) were larger particles found. To identify matrix elements that might give rise to tri-and tetramolecular crosslinking arrangements, we analyzed critical point dried fine fibrin clots (Fig. 4) , which consist of a branching network of thin twisting fibrils (66, 67) . The narrowest of these are double-stranded (7-13) and have widths of 13.0 ± 2.0 nm (n = 38; range, 8.3-17.5 nm). Two types of trifunctional junctions were identified on the basis of fibril width measurements. The first is well known and consists of a four-stranded fibril 21.8 ± 2.4 nm wide (n = 39; range, 17-28 nm) that is formed from, or bifurcated into, two 13-nm thin fibrils (arrowheads)-the tetramolecular branch point. The second type, which we term the trimolecular branch point, has not previously been described, and is composed of three 13-nm thin fibrils (arrows). The molecular basis for this structure is considered further below.
DISCUSSION
The foregoing data indicate the existence of two heretofore unidentified fibrin degradation products, D trimer and D tetramer, derived from fibrin molecules crosslinked by trimeric and tetrameric y chains, respectively. The evidence supporting this conclusion includes (i) NaDodSO4/PAGE and crossed immunoelectrophoresis of digests of crosslinked fibrin demonstrated two plasmin-resistant D-containing core fragments of =300 and =365 kDa, respectively; (ii) TEM images and STEM mass analyses revealed structures corresponding in shape and size to trimeric and tetrameric forms of fragment D. Their existence is inconsistent with the assumption that every crosslinked degradation product larger than D dimer must contain one or more covalently linked E domains (36, (43) (44) (45) and raises the question as to whether certain E-containing digest components, especially those that are about the same size as D trimers or D tetramers (e.g., YY, 290 kDa; XY, 385 kDa), have been overestimated or, under certain conditions, misidentified. The discovery oftrimeric and tetrameric y-chain remnants, and the corresponding forms of crosslinked D fragments, indicates that e-(y-Glu)Lys bridging of these chains differs from the reciprocal bridging pattern that characterizes D dimers (Fig. 1) . Since there is only one donor lysine residue at y-406 (25, 26) , we assume that trimeric and tetrameric crosslinked structures form by utilization of that same residue. Four bond arrangements can account for these structures (Fig. 5) . Closed tripartite or tetrapartite loops of E-(yGlu)Lys bridges utilizing all y-406 lysine donors would result in structures Ia or Ila, respectively. Trimers and tetramers would also result if only two of three (Ib) or three of four (lIb) y-406 lysine donors were utilized, and would create an open arrangement, such as we have visualized (Fig. 3) . It also seems possible that open trimeric or tetrameric structures utilizing all y-406 lysine donors could result from bridging at two adjacent glutamine acceptors on one y chain, but this is unlikely since concomitant utilization of adjacent glutamine residues in model substrates does not take place (68) .
Given (19) (20) (21) 71) . The trans configuration appears likely to be a function of constraints imposed within assembled fibers by the complementary noncovalent associations between E and D domains that govern the assembly process (1) (2) (3) (4) (5) (6) . In the absence of these constraints (e.g., fibrinogen dimers), more extended bond orientations become possible and perhaps even likely.
By analysis of fibrin fibril widths, we have identified two different types oftrifunctional branches. The first of these has been proposed as the sole basis for network branching (11, (18) (19) (20) (21) and consists of a pair of double-stranded fibrils that become laterally associated to form a four-stranded fibril (Fig. 5) -the tetramolecular branch point. The second type, the trimolecular branch point, is composed of three doublestranded fibrils. This newly discovered structure evidently forms through occupancy of an E (or D) domain polymerization site within a bimolecular fibril by the corresponding complementary domain from an extraneous fibrin molecule (Fig. 5) . Further interactions between D and E domains of other molecules serve to complete the structure. The presence of an additional fibrin molecule at such ajunction makes it possible to form trimolecular y-chain crosslinks without disturbing the symmetry or register of reciprocal transoriented dimeric bridges and suggests that at least some trimeric y-chain structures form at trimolecular branch points, with the remainder originating at sites of lateral fiber associations. With respect to crosslinked tetramolecular structures, however, it cannot be deduced as yet whether any such structures originate at branch points. 
